I’ve updated some existing positions since I last added info to this blog, so here’s a recap:
JAVA:
Deal to be bought by Oracle instead of IBM. (Approved by shareholders on July 16, 2009). New offer price: $9.50/sh cash. Not sure on deal close date, so I will assume 12/31/2009. My entry was $8.20. I decide to [...]
Ok, so I am buying a position in WYE for my simulated portfolio today. Entry price: $42.87.
Here’s the number crunch:
Deal terms: $33 cash plus 0.985 shares of PFE per share of WYE.
Entry price of WYE: $42.87
PFE today: $14.26
Deal says I get: 0.985 * $14.26 = $14.046 per sh of WYE plus another $33 per sh [...]
Well, it’s not an all cash deal, so this one is a little more tricky. Now PFE’s stock price is part of the equation:
“The New York-based company will pay $50.19 — $33 in cash and 0.985 share of its stock — for each Wyeth share. That represents a 29 percent premium over Wyeth’s closing share [...]
Pfizer Inc. (PFE) said it is in talks to buy Wyeth (WYE). WSJ reports that they have been talking for months now and are not close to a deal yet:
“The two sides have been in discussions for months and a deal isn’t imminent, the people said. Given recent market volatility and overall economic uncertainty, the [...]
